EMMA · Emmaus Life Sciences, Inc. · Investor Relations
$0.03
+0.01 (+22.99%)
At close · Aug 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the Company's existing cash balance and anticipated cash flows cannot satisfy its current debt and ongoing obligations, combined with the uncommitted nature of the Company's financing plans, there is substantial doubt about the Company’s ability to continue as a going concern for 12 months from the date that these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.25M
Shares
70.19M
Volume · Aug 21
847.1K
Avg daily vol (3M)
157.21K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-03 | Emmaus Corporate Overview 08/26 | Event |
| 2022-04-27 | Emmaus Corporate Overview 04/22 | Event |
Source: https://ir.emmausmedical.com/